Onderneming Apyx Medical Corp Nasdaq
Aandelen
US03837C1062
Medische apparatuur, benodigdheden & distributie
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Advanced Energy
82,9
%
| 37 | 82,7 % | 43 | 82,9 % | +17,88% |
Original Equipment Manufacturing
17,1
%
| 8 | 17,3 % | 9 | 17,1 % | +16,35% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
73,2
%
| 31 | 70,1 % | 38 | 73,2 % | +22,87% |
International
26,8
%
| 13 | 29,9 % | 14 | 26,8 % | +5,28% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Charles Goodwin
CEO | Chief Executive Officer | 58 | 15-12-17 |
Matthew Hill
DFI | Director of Finance/CFO | 56 | 04/12 |
Kari Larson
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-19 |
Shawn D. Roman
CTO | Chief Tech/Sci/R&D Officer | - | 27-10-14 |
Christopher Corp
PRN | Corporate Officer/Principal | - | - |
Laura Iversen
PRN | Corporate Officer/Principal | - | 22-10-18 |
Todd Hornsby
PRN | Corporate Officer/Principal | 48 | 25-08-14 |
Tom Craig
SAM | Sales & Marketing | - | - |
Vera MacElroy
HRO | Human Resources Officer | 74 | 01-01-00 |
Corporate Officer/Principal | 71 | 01-10-93 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lawrence Waldman
BRD | Director/Board Member | 77 | 15-03-11 |
Craig Swandal
BRD | Director/Board Member | 63 | 09-03-18 |
John Andres
BRD | Director/Board Member | 66 | 17-07-14 |
Michael Geraghty
BRD | Director/Board Member | 76 | 15-03-11 |
Director/Board Member | 76 | 01-08-19 | |
Charles Goodwin
CEO | Chief Executive Officer | 58 | 15-12-17 |
Wendy Levine
BRD | Director/Board Member | 51 | 25-08-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 34 643 926 | 28 435 354 ( 82,08 %) | 0 | 82,08 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,81% | 180 mld. | |
-1,63% | 106 mld. | |
-4,14% | 67,55 mld. | |
-6,56% | 46,11 mld. | |
+13,22% | 45,79 mld. | |
+6,13% | 41,61 mld. | |
+19,93% | 31,07 mld. | |
+13,61% | 24,77 mld. | |
-5,36% | 24,27 mld. |